← Leaderboards
John Hwa
Yale University
$13,604,925
Attributed
$14,191,235
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,237,683 · 7
By mechanism
R01$14,191,235 · 6
U54$2,046,448 · 1
Top collaborators
- Diane S. Krause3 shared
- Hyung Joon Chun1 shared
- Edward Vincent Faustino1 shared
Most similar at Yale University
Same institution · by research overlap
- Margretta Seashore$51,578
- Albert J Sinusas$22,904,679
- Adam H. De Havenon$5,725,083
- Chi Liu$11,811,709
- Kim Germaine Smolderen$1,112,640
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayCardiovascular SystemThrombosisBlood PlateletsMediatingMorbidity - Disease RateEventBaseDiabetes MellitusFunctional DisorderInsightDiabetic PatientSignal TransductionDiabeticCardiovascular DiseasesPathway InteractionsBlood VesselsMolecularApoptosisProstaglandins IPreventCellsNew Therapeutic TargetInternational
Grant awards (36)
Platelet dysfunction in pediatric multiple organ dysfunction syndrome: Role of unfolded protein response$644,061
R01 · FY2025 · HD
Yale Cooperative Center of Excellence in Hematology$813,849
U54 · FY2024 · DK
Yale Cooperative Center of Excellence in Hematology$418,750
U54 · FY2024 · DK
Yale Cooperative Center of Excellence in Hematology$813,849
U54 · FY2023 · DK
Platelets in vascular injury repair$563,947
R01 · FY2023 · HL · contact PI
Platelet mitochondrial function in health and disease$505,822
R01 · FY2023 · HL · contact PI
Platelets in vascular injury repair$563,947
R01 · FY2022 · HL · contact PI
Platelet mitochondrial function in health and disease$505,822
R01 · FY2022 · HL · contact PI
Platelets in vascular injury repair$563,947
R01 · FY2021 · HL · contact PI
Role of Endothelial Regulation of Fatty Acid Uptake in Metabolic Dysfunction$528,560
R01 · FY2021 · HL · contact PI
Platelet mitochondrial function in health and disease$505,822
R01 · FY2021 · HL · contact PI
Platelets in vascular injury repair$563,947
R01 · FY2020 · HL · contact PI
Platelet mitochondrial function in health and disease$505,822
R01 · FY2020 · HL · contact PI
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus$418,750
R01 · FY2019 · HL · contact PI
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus$418,750
R01 · FY2019 · HL · contact PI
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus$418,750
R01 · FY2018 · HL · contact PI
Platelet Mitochondrial Function in Health and Disease$416,250
R01 · FY2018 · HL · contact PI
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus$418,750
R01 · FY2017 · HL · contact PI
Platelet Mitochondrial Function in Health and Disease$416,250
R01 · FY2017 · HL · contact PI
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus$71,506
R01 · FY2017 · HL · contact PI
Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus$418,750
R01 · FY2016 · HL · contact PI
Platelet Mitochondrial Function in Health and Disease$416,250
R01 · FY2016 · HL · contact PI
Platelet Mitochondrial Function in Health and Disease$416,250
R01 · FY2015 · HL · contact PI
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus$410,006
R01 · FY2015 · HL · contact PI
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus$407,925
R01 · FY2014 · HL · contact PI
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus$396,270
R01 · FY2013 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$389,951
R01 · FY2013 · HL · contact PI
Hyperglycemia, thromboxane and platelet activity in diabetes mellitus$415,104
R01 · FY2012 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$409,613
R01 · FY2012 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$413,750
R01 · FY2011 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$413,750
R01 · FY2010 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$399,750
R01 · FY2009 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor$303,228
R01 · FY2007 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$312,285
R01 · FY2006 · HL · contact PI
Pharmacogenetics of the human prostacyclin receptor.$319,550
R01 · FY2005 · HL
Pharmacogenetics of the human prostacyclin receptor$318,100
R01 · FY2004 · HL